FDA Clearance Tracker · P140031-S172
Edwards SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve
Last checked: Nov 20, 2026Latest source record: Jun 21, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Jun 21, 2024
Approved
Time to decision
85 days
Received Mar 28, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P140031-S172
- Device name
- Edwards SAPIEN 3 Ultra RESILIA Transcatheter Heart Valve
- Applicant
- Edwards Lifesciences, LLC
- Applicant location
- Irvine, CA
- Received
- Mar 28, 2024
- Decided
- Jun 21, 2024
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Location Change - Manufacturer/Sterilizer/Packager/Supplier
- Original approval
- P140031
Device type
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
approval for a sterilization manufacturing site located at Steris Applied Sterilization Technologies (AST), Isomedix Operations, Inc., 43425 Business Park Drive Temecula, California 92590
Source documents
Other decisions for Edwards Lifesciences, LLC
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- PASCAL Precision Transcatheter Valve Repair SystemPMA supplement
P220003-S029 · Decided Oct 20, 2026 · 180 days after receipt · Panel Track
Device type: Tricuspid valve repair device, percutaneously delivered (NPS) · Cardiology
P260007 · Decided Oct 1, 2026 · 234 days after receipt
Device type: Heart-valve, polymeric (SJL) · Cardiology
K251326 · Decided Jun 11, 2026 · 408 days after receipt
Device type: Monitor, Breathing Frequency (BZQ) · Anesthesiology & Respiratory
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.